Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Last updated: April 2019
Remove filter for
Last updated: 2019
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 13 of 13 items.
Undeclared drug ingredients may pose serious health risks
AlertForeign product alert | 2019-04-30
PMS-Cetirizine tablets (2019-04-26)
RecallHealth product recall | 2019-04-26
Multiple unauthorized prescription drugs seized from Vanier store in Ottawa, Ontario, may pose serious health risks
AlertPublic advisory | 2019-04-25
Keytruda (2019-04-23)
RecallHealth product recall | 2019-04-23
Auro Pharma Inc. voluntarily recalls one lot of Auro-Irbesartan HCT tablets because of nitrosamine impurity
AlertInformation update | 2019-04-18
Centre for Probe Development and Commercialization Products Recall (2019-04-17)
RecallHealth product recall | 2019-04-17
Auro-Irbesartan HCT Tablet (2019-04-17)
RecallHealth product recall | 2019-04-17
Ibuprofen tablets (2019-04-16)
RecallHealth product recall | 2019-04-16
Health Canada approves updates to Mifegymiso prescribing information: Ultrasound no longer mandatory
AlertInformation update | 2019-04-16
Multiple unauthorized eye solutions and an acne gel sold at two stores in the Lower Mainland of BC may pose serious health risks
AlertPublic advisory | 2019-04-15
Hydromorph Contin - Controlled Release Capsule 24 mg (2019-04-12)
RecallHealth product recall | 2019-04-12
PMS-Sulfasalazine product recall (2019-04-09)
RecallHealth product recall | 2019-04-09
Multiple unauthorized health products sold at Sunrise Lee Chinese Herbs Centre in Calgary, Alberta, may pose serious health risks
AlertPublic advisory | 2019-04-05